Wen Hsiang Lai
Président chez CENTURY IRON AND STEEL INDUSTRIAL CO.,LTD.
Fortune : 116 M $ au 30/06/2024
Provenance du réseau au premier degré de Wen Hsiang Lai
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Building Products | 17 | |
| Public Company | Alternative Power Generation | 10 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Wen Hsiang Lai via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| FARCENT ENTERPRISE CO.,LTD | Household/Personal Care | Director/Board Member | |
| YI CHUN GREEN TECHNOLOGY CO., LTD. | Environmental Services | Chairman | |
| TAIWAN GLASS IND. CORP. | Industrial Specialties | Director/Board Member | |
| National Taiwan University | College/University | Graduate Degree | |
| FORMOSA TAFFETA CO., LTD. | Textiles | Chief Executive Officer | |
| KENDA RUBBER INDUSTRIAL CO. LTD. | Automotive Aftermarket | Director/Board Member | |
| SWANCOR HOLDING CO., LTD. | Chemicals: Specialty | Director/Board Member | |
| National Chung Hsing University | College/University | Undergraduate Degree | |
Yi-Chiu International Development Co. Ltd.
 Yi-Chiu International Development Co. Ltd. Financial ConglomeratesFinance Yi-Chiu International Development Co. Ltd. is a Taiwanese company that provides investment and management consulting services. The private company is based in New Taipei, Taiwan. The company was founded in 2012. | Financial Conglomerates | Director/Board Member | |
| CHINA STEEL CORPORATION | Steel | Director/Board Member | |
UWELL Biopharma, Inc.
 UWELL Biopharma, Inc. Pharmaceuticals: MajorHealth Technology UWELL Biopharma, Inc. is a biotech company founded in 2003 and based in New Taipei, Taiwan. The Taiwanese company specializes in developing new cancer drugs using chimeric antigen receptor T-cell (CAR-T) technology. CAR-T therapy involves engineering a patient's T-cells to recognize and attack cancer cells. UWELL is currently conducting an open, single-center phase I clinical trial to evaluate the safety and efficacy of its anti-CD19 CAR-T cell injection in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma. The study has been approved by the Institutional Review Board of Tri-Service General Hospital and the Ministry of Health and Welfare. UWELL has achieved success in treating adult blood cancer patients with CAR-T therapy, as evidenced by the clearance of cancer cells in the first case treated at Tri-Service General Hospital. | Pharmaceuticals: Major | Director/Board Member | |
| Yi Chou Group | Chairman | ||
| University of Tamkang | College/University | Undergraduate Degree | |
| NORTH-STAR INTERNATIONAL CO., LTD. | Specialty Stores | Director/Board Member | |
Century Huaxin Wind Energy Co. Ltd.
 Century Huaxin Wind Energy Co. Ltd. SteelNon-Energy Minerals Century Huaxin Wind Energy Co. Ltd. provides engineering services. It also engages in the iron and steel casting, secondary processing, manufacturing of machinery and building component. The company was founded on February 26, 2020 and is headquartered in Taoyuan, Taiwan. | Steel | Director/Board Member | |
| HSIN KUANG STEEL COMPANY LIMITED | Steel | Chief Executive Officer | |
| SIMULA TECHNOLOGY INC. | Electronic Components | Director/Board Member |
Statistiques
Internationale
| Taïwan | 18 |
Sectorielle
| Process Industries | 4 |
| Consumer Services | 4 |
| Non-Energy Minerals | 4 |
| Consumer Non-Durables | 2 |
| Industrial Services | 2 |
Opérationnelle
| Director/Board Member | 33 |
| Independent Dir/Board Member | 14 |
| Chief Executive Officer | 5 |
| Chairman | 4 |
| Public Communications Contact | 4 |
Relations les plus connectées
- Bourse
- Insiders
- Wen Hsiang Lai
- Connexions Sociétés
